· Neonate
· Summary table
· Pharmacokinetics: ADME
· (Pharmacodynamics)
· 0-28 days old
· Born 37-40 weeks gestation
· All changes more pronounced if premature
|
Morphine |
Bupivacaine |
Suxamethonium |
Type |
Opioid analgesic |
Amide local anaesthetic |
Depolarising muscle relaxant |
Dose |
0.1-0.2mg/kg 3kg baby: 0.3-0.6mg |
Max 2mg/kg 3kg baby: 6mg |
1-2mg/kg 3kg baby: 3-6mg |
Toxicity |
M: sedation, resp depression M6G: same M3G: neurotoxicity, seizure |
CNS: seizure, coma CVS: arrhythmia, arrest |
Desensitisation blockade Bradyarrhythmia |
Neonate cf. adult |
↑Sensitivity to opioid ↑M3G toxicity ↓Metabolism |
↑Sensitivity ↓Metabolism |
Kinetic changes cancel out ↑Sensitivity ↑Risk bradyarrhythmia |
Oral |
· Vomiting, GORD -> unreliable effect PO morphine · ↓Absorption rate until 6-8 months (↓rate of onset PO morphine) · ↓Intestinal transit speed -> ↑oral bioavailability of morphine |
Inhaled |
· VA:FRC ratio 5:1 cf. 1.5:1 -> ↑rate of rise FA/FI volatiles (overrides cardiac output) |
IM |
· ↑Muscle blood flow -> rate of absorption of suxamethonium |
SC / transdermal |
· ↑Cardiac output:surface area -> ↑skin blood flow -> ↑rate of absorption S/C morphine |
↑Cardiac output |
· ↑Rate of onset suxamethonium · ↓Rate of ↑ FA/FI volatile anaesthetic (overridden by ↑VA:FRC) |
Blood |
· ↑Blood volume · ↓Blood fat content -> ↓blood:gas partition coefficient volatiles · ↓pH 7.3 -> ↑ionisation of basic drugs e.g. bupivacaine -> ↓toxicity (minor effect) · ↓Albumin -> ↑%free bupivacaine -> ↑toxicity · ↓AAG -> ↑%free basic drugs -> toxicity (e.g. morphine) |
Tissues |
· ↑Total body water -> ↑VD water-soluble drugs e.g. suxamethonium · ↓Muscle mass -> ↑sensitivity to suxamethonium · ↓Fat mass -> ↓uptake of lipid-soluble drugs -> toxicity (e.g. bupivacaine) · Immature blood brain barrier -> ↑uptake of morphine (only 23% unionized) -> toxicity |
Brain |
· Permeable blood-brain barrier -> ↑toxicity if o Highly ionised (e.g. morphine 77%, bupivacaine 85%) o Hydrophilic (e.g. M3G, M6G) |
|
Enzyme systems mature at different rates |
↓Phase 1 reactions |
· ↓Rate of bupivacaine metabolism -> ↑toxicity · Products: pipecolic acid, pipecolyxylidine |
↓Phase 2 reactions |
· ↓Rate of morphine metabolism -> ↑toxicity · Products: morphine-3-glucuronide, morphine-6-glucuronide |
↓Plasma cholinesterase |
· ↓Rate of suxamethonium metabolism -> ↑toxicity · Products: succinylmonocholine + choline -> succinic acid + another choline |
↓GFR |
· Initially 10% of adult; normalised at 6 months · ↓Elimination of M3G and M6G -> ↑toxicity |
↓Tubular secretion |
· Relevant to other drugs |
Immature resp centre |
· ↑Morphine toxicity |
Immature NMJ |
· ↓Reserve of ACh -> myasthaenic response to suxamethonium |
Feedback welcome at ketaminenightmares@gmail.com